How a potent antifibrotic peptide works and why it could reverse scarring in multiple organs
Biosimilar drugs could generate $38.4 billion in savings over five years
10 January 2022In 1st, US surgeons transplant pig heart into human patient
10 January 2022How a potent antifibrotic peptide works and why it could reverse scarring in multiple organs
A research team at the Medical University of South Carolina (MUSC) led by Carol Feghali-Bostwick, Ph.D., reports in the Journal of Clinical Investigation (JCI) Insight that the E4 peptide reverses fibrosis, or scarring, in human and mouse tissues by activating an antifibrotic pathway that is common to all organ systems.
